Source link : https://www.newshealth.biz/health-news/dupilumab-effective-in-ppi-refractory-pediatric-eoe/
Good news for younger children suffering from the uncommon but debilitating gastrointestinal condition eosinophilic esophagitis (EoE). A randomized placebo-controlled study found the monoclonal antibody dupilumab (Dupixent) led to histologic remission in significantly more affected children than placebo. Data from this trial led to a January US Food and Drug Administration (FDA) approval of the anti-inflammatory […]
Author : News Health
Publish date : 2024-07-04 11:16:54
Copyright for syndicated content belongs to the linked Source.
Categories